The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| MCGRAW HILL INC | COM | 580907103 | 23,201,500 | 2,450,000 | SH | SOLE | NONE | 2,450,000 | 0 | 0 | |
| OCCIDENTAL PETE CORP | COM | 674599105 | 12,142,500 | 250,000 | SH | SOLE | NONE | 250,000 | 0 | 0 | |
| AMNEAL PHARMACEUTICALS INC | COM STK CL A | 03168L105 | 22,503,000 | 1,300,000 | SH | SOLE | NONE | 1,300,000 | 0 | 0 | |
| ARBUTUS BIOPHARMA CORP | COM | 03879J100 | 12,000,000 | 2,500,000 | SH | SOLE | NONE | 2,500,000 | 0 | 0 | |
| AZUL S A | SPONSORED ADS | 05501U601 | 15,140,850 | 1,684,188 | SH | SOLE | NONE | 1,684,188 | 0 | 0 | |
| CALIFORNIA RES CORP | COM STOCK | 13057Q305 | 9,252,250 | 175,000 | SH | SOLE | NONE | 175,000 | 0 | 0 | |
| COGENT COMMUNICATIONS HLDGS | COM NEW | 19239V302 | 3,470,000 | 250,000 | SH | SOLE | NONE | 250,000 | 0 | 0 | |
| DIVERSIFIED HEALTHCARE TR | COM SH BEN INT | 25525P107 | 37,897,500 | 4,075,000 | SH | SOLE | NONE | 4,075,000 | 0 | 0 | |
| NEXTERA ENERGY INC | COM | 65339F101 | 29,402,950 | 335,000 | SH | SOLE | NONE | 335,000 | 0 | 0 | |
| OSCAR HEALTH INC | CL A | 687793109 | 49,910,000 | 1,750,000 | SH | Put | SOLE | NONE | 1,750,000 | 0 | 0 |
| PRIVIA HEALTH GROUP INC | COM | 74276R102 | 40,782,050 | 1,585,000 | SH | SOLE | NONE | 1,585,000 | 0 | 0 | |
| RESMED INC | COM | 761152107 | 38,976,000 | 200,000 | SH | Put | SOLE | NONE | 200,000 | 0 | 0 |
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 597,416,000 | 800,000 | SH | Put | SOLE | NONE | 800,000 | 0 | 0 |
| UNITEDHEALTH GROUP INC | COM | 91324P102 | 27,015,950 | 65,000 | SH | SOLE | NONE | 65,000 | 0 | 0 | |
| UNITEDHEALTH GROUP INC | COM | 91324P102 | 41,563,000 | 100,000 | SH | Call | SOLE | NONE | 100,000 | 0 | 0 |
| VENTURE GLOBAL INC | COM CL A | 92333F101 | 19,477,500 | 1,750,000 | SH | SOLE | NONE | 1,750,000 | 0 | 0 | |
| VENTURE GLOBAL INC | COM CL A | 92333F101 | 33,390,000 | 3,000,000 | SH | Call | SOLE | NONE | 3,000,000 | 0 | 0 |
| VIKING THERAPEUTICS INC | COM | 92686J106 | 23,406,000 | 600,000 | SH | SOLE | NONE | 600,000 | 0 | 0 | |
| VIKING THERAPEUTICS INC | COM | 92686J106 | 9,752,500 | 250,000 | SH | Call | SOLE | NONE | 250,000 | 0 | 0 |
| VIVID SEATS INC | COM CL A | 92854T209 | 3,260,000 | 500,000 | SH | SOLE | NONE | 500,000 | 0 | 0 | |
| WARBY PARKER INC | CL A COM | 93403J106 | 12,136,000 | 400,000 | SH | Put | SOLE | NONE | 400,000 | 0 | 0 |
| NIQ GLOBAL INTELLIGENCE PLC | ORDINARY SHARES | G63755105 | 27,151,110 | 2,903,862 | SH | SOLE | NONE | 2,903,862 | 0 | 0 | |
| ROIVANT SCIENCES LTD | SHS | G76279101 | 70,780,000 | 2,000,000 | SH | SOLE | NONE | 2,000,000 | 0 | 0 | |
| NXP SEMICONDUCTORS N V | COM | N6596X109 | 25,292,700 | 90,000 | SH | SOLE | NONE | 90,000 | 0 | 0 | |